Перейти к основному содержанию

User account menu

  • Войти

Языки

  • English
  • Français
  • Português
  • Español
  • العربية
  • Pусский

Основная навигация

  • Про ISSUP

    • Обоснование ISSUP
    • Членство
      • Критерии членства
      • Этический кодекс
      • Who is ISSUP for?
    • Новости
    • Международные партнеры
    • Управление
    • ISSUP Scientific Council
    • Friends of ISSUP (USA)
    • Семинары ISSUP
      • Bali 2025
      • Thessaloniki 2024
      • Buenos Aires 2023
      • Manila 2022
      • Abu Dhabi 2022
      • International Conference 2021 (Virtual)
      • Africa 2020 (Virtual)
      • Vienna 2019
      • Nairobi 2018
      • Cancún 2017
      • ISSUP Campinas 2016
      • ISSUP Tailandia 2015
    • Награды ISSUP
      • Награда за научно обоснованный подход
      • Награда за местную инициативу
      • Награда за заслуги
      • Высшее качество обучения
      • Награда за выдающийся вклад в развитие ISSUP
    • Страницы памяти
    • Acknowledgements
    • Путеводитель по сайту ISSUP
    • Свяжитесь с ISSUP
    • FAQs - Frequently Asked Questions
  • Профессиональное развитие

    • Центр онлайн-обучения
      • Как зарегистрироваться
      • Самостоятельные курсы UTC
    • Универсальные учебные программы (UPC/UTC)
      • Универсальная учебная программа по профилактике
      • Универсальная учебная программа по лечению
      • Универсальная учебная программа по восстановлению
      • Доступ к тренингам UPC и UTC
      • Поставщики обучения
      • Станьте поставщиком обучения
      • Глобальная программа обучения
    • Ресурсы
      • Glossary
      • Вебинары ISSUP
      • INEP Plus
      • Prevention Insights Video Series
      • Prevention Lists
      • Сертификация ICAP
      • HealthEKnowledge
      • WiRED International
      • Качество в лечении
      • Учебник по профилактике SPR-ISSUP
    • Доска вакансий
  • Knowledge Share

    • Search in the Knowledge Share
    • ADDICTOLOGY Journal
      • Последний номер
  • Национальные отделения

    • Africa
      • ISSUP Botswana
      • ISSUP Côte d’Ivoire
      • ISSUP Egypt
      • ISSUP The Gambia
      • ISSUP Kenya
      • ISSUP Namibia
      • ISSUP Nigeria
      • ISSUP South Africa
      • ISSUP Tanzania
      • ISSUP Togo
      • ISSUP Uganda
    • The Americas
      • ISSUP Argentina
      • ISSUP The Bahamas
      • ISSUP Brazil
      • ISSUP Canada
      • ISSUP Chile
      • ISSUP Colombia
      • ISSUP Ecuador
      • ISSUP El Salvador
      • ISSUP Guatemala
      • ISSUP Mexico
      • ISSUP Panama
      • ISSUP Paraguay
      • ISSUP Peru
      • ISSUP United States
    • Asia
      • ISSUP Afghanistan
      • ISSUP India
      • ISSUP Indonesia
      • ISSUP Kazakhstan
      • ISSUP Lebanon
      • ISSUP Malaysia
      • ISSUP in Pakistan
      • ISSUP Philippines
      • ISSUP Qatar
      • ISSUP Sri Lanka
      • ISSUP Thailand
      • ISSUP Türkiye
      • ISSUP United Arab Emirates
      • ISSUP Uzbekistan
      • ISSUP Vietnam
    • Europe
      • ISSUP Czech Republic
      • ISSUP Greece
      • ISSUP Italy
      • ISSUP Spain
      • ISSUP Ukraine
      • ISSUP United Kingdom
    • Как стать национальным отделением
    • Консультативный комитет национальных отделений ISSUP
  • Events

    • Search through all events
  • Сети

    • A–Z
  • Мой ISSUP

    • Member Directory
    • Подать заявку на членство

Opioids

Network for information about opioids
DiscussionsФайлыИзображенияVideosСсылкиМероприятияОбмен знаниямиВсе
Jose Luis Vazquez Martinez

USA Federal Drug Testing Program Adds Fentanyl Testing

Jose Luis Vazquez Martinez - 16 January 2025
Source: https://www.govinfo.gov/content/pkg/FR-2025-01-16/pdf/2025-00425.pdf The U.S. Department of Health and Human Services (HHS) added fentanyl to its drug testing protocol. The revised drug testing panels will go into effect on July 7, 2025.
USA Federal Drug Testing Program Adds Fentanyl Testing.pdf
  • Подробнее о USA Federal Drug Testing Program Adds Fentanyl Testing
  • Добавить комментарий
Jose Luis Vazquez Martinez

Frontal White Matter Changes and Craving Recovery in Inpatients With Heroin Use Disorder

Jose Luis Vazquez Martinez - 19 December 2024
Source: Gaudreault P, King SG, Huang Y, et al. Frontal White Matter Changes and Craving Recovery in Inpatients With Heroin Use Disorder. JAMA Netw Open. 2024;7(12):e2451678. doi:10.1001/jamanetworkopen.2024.51678 Key Points Question Does white matter microstructure change during medication-assisted...
Frontal White Matter Changes and Craving Recovery in Inpatients With Heroin Use Disorder.pdf
  • Подробнее о Frontal White Matter Changes and Craving Recovery in Inpatients With Heroin Use Disorder
  • Добавить комментарий
Jose Luis Vazquez Martinez

The association between glucose-dependent insulinotropic polypeptide and/or glucagon-like peptide-1 receptor agonist prescriptions and substance-related outcomes in patients with opioid and alcohol use disorders: A real-world data analysis

Jose Luis Vazquez Martinez - 17 October 2024
Source: Qeadan F, McCunn A, Tingey B. The association between glucose-dependent insulinotropic polypeptide and/or glucagon-like peptide-1 receptor agonist prescriptions and substance-related outcomes in patients with opioid and alcohol use disorders: A real-world data analysis. Addiction. 2024...
The association between glucose-dependent insulinotropic polypeptide and or glucagon-like peptide-1 receptor agonist prescriptions and substance-related outcomes in patients with opioid and alcohol use disorders.pdf
  • Подробнее о The association between glucose-dependent insulinotropic polypeptide and/or glucagon-like peptide-1 receptor agonist prescriptions and substance-related outcomes in patients with opioid and alcohol use disorders: A real-world data analysis
  • Добавить комментарий
Jose Luis Vazquez Martinez

Prevalence of problematic pharmaceutical opioid use in patients with chronic non-cancer pain: A systematic review and meta-analysis

Jose Luis Vazquez Martinez - 30 August 2024
Source: Thomas, K. H., Dalili, M. N., Cheng, H. Y., Dawson, S., Donnelly, N., Higgins, J. P., & Hickman, M. (2024). Prevalence of problematic pharmaceutical opioid use in patients with chronic non‐cancer pain: A systematic review and meta‐analysis. Addiction. Abstract Background and aims Chronic non...
Prevalence of problematic pharmaceutical opioid use in patients with chronic non-cancer pain A systematic review and meta-analysis.pdf
  • Подробнее о Prevalence of problematic pharmaceutical opioid use in patients with chronic non-cancer pain: A systematic review and meta-analysis
  • Добавить комментарий
Jose Luis Vazquez Martinez

A telemedicine bridge clinic improves access and reduces cost for opioid use disorder care

Jose Luis Vazquez Martinez - 29 March 2024
Source: Lynch, M., Vargas, D., Winger, M. E., Kanter, J., Meyers, J., Schuster, J., & Yealy, D. (2024). A Telemedicine Bridge Clinic Improves Access and Reduces Cost for Opioid Use Disorder Care. Drug and Alcohol Dependence Reports, 100227. Highlights -A Telemedicine Bridge Clinic effectively...
A telemedicine bridge clinic improves access and reduces cost for opioid use disorder care_0.pdf
  • Подробнее о A telemedicine bridge clinic improves access and reduces cost for opioid use disorder care
  • Добавить комментарий
Jose Luis Vazquez Martinez

Pharmacological and Behavioral Treatment of Opioid Use Disorder

Jose Luis Vazquez Martinez - 26 March 2024
Source: Sofuoglu, M., DeVito, E. E., & Carroll, K. M. (2019). Pharmacological and behavioral treatment of opioid use disorder. Psychiatric Research and Clinical Practice, 1(1), 4-15. Abstract Objective: Opioid use disorder (OUD) in the United States has surged, with an estimated 2.5 million needing...
Pharmacological and Behavioral Treatment of Opioid Use Disorder.pdf
  • Подробнее о Pharmacological and Behavioral Treatment of Opioid Use Disorder
  • Добавить комментарий
Jose Luis Vazquez Martinez

Methadone Induction in Primary Care for Opioid Dependence: A Pragmatic Randomized Trial (ANRS Methaville)

Jose Luis Vazquez Martinez - 22 March 2024
Source: Carrieri PM, Michel L, Lions C, Cohen J, Vray M, Mora M, et al. (2014) Methadone Induction in Primary Care for Opioid Dependence: A Pragmatic Randomized Trial (ANRS Methaville). PLoS ONE 9(11): e112328. https://doi.org/10.1371/journal.pone.0112328 Abstract Objective Methadone coverage is...
Methadone Induction in Primary Care for Opioid Dependence A Pragmatic Randomized Trial ANRS Methaville_0.pdf
  • Подробнее о Methadone Induction in Primary Care for Opioid Dependence: A Pragmatic Randomized Trial (ANRS Methaville)
  • Добавить комментарий
Jose Luis Vazquez Martinez

Tools to implement measurement-based care (MBC) in the treatment of opioid use disorder (OUD): toward a consensus

Jose Luis Vazquez Martinez - 29 February 2024
Source: Rush, A.J., Gore-Langton, R.E., Bart, G. et al. Tools to implement measurement-based care (MBC) in the treatment of opioid use disorder (OUD): toward a consensus. Addict Sci Clin Pract 19, 14 (2024). https://doi.org/10.1186/s13722-024-00446-w Abstract Background The prevalence and associated...
Tools to implement measurement-based care (MBC) in the treatment of opioid use disorder (OUD) toward a consensus.pdf
  • Подробнее о Tools to implement measurement-based care (MBC) in the treatment of opioid use disorder (OUD): toward a consensus
  • Добавить комментарий
Jose Luis Vazquez Martinez

Canadian Addiction Treatment Centre (CATC) opioid agonist treatment cohort in Ontario, Canada

Jose Luis Vazquez Martinez - 27 February 2024
Source: Morin KA, Tatangelo M, Marsh D. Canadian Addiction Treatment Centre (CATC) opioid agonist treatment cohort in Ontario, Canada. BMJ Open 2024;14:e080790. doi: 10.1136/bmjopen-2023-080790 Abstract Purpose The Canadian Addiction Treatment Centre (CATC) cohort was established during a period of...
Canadian Addiction Treatment Centre (CATC) opioid agonist treatment cohort in Ontario, Canada.pdf
  • Подробнее о Canadian Addiction Treatment Centre (CATC) opioid agonist treatment cohort in Ontario, Canada
  • Добавить комментарий
Jose Luis Vazquez Martinez

Xylazine-associated Wounds: Clinical Experience From a Low-barrier Wound Care Clinic in Philadelphia

Jose Luis Vazquez Martinez - 27 February 2024
Source: McFadden, Rachel MPH, BSN, RN; Wallace-Keeshen, Sara FNP-BC; Petrillo Straub, Kristi AGNP-C; Hosey, Rebecca A. MPH, BSN, RN; Neuschatz, Rachel MSN, RN; McNulty, Keara BSN, RN; Thakrar, Ashish P. MD, MS. Xylazine-associated Wounds: Clinical Experience From a Low-barrier Wound Care Clinic in...
xylazine_associated_wounds__clinical_experience_0.pdf
  • Подробнее о Xylazine-associated Wounds: Clinical Experience From a Low-barrier Wound Care Clinic in Philadelphia
  • Добавить комментарий
Jose Luis Vazquez Martinez

Overdose Prevention Centers, Crime, and Disorder in New York City

Jose Luis Vazquez Martinez - 21 November 2023
Source: Chalfin A, del Pozo B, Mitre-Becerril D. Overdose Prevention Centers, Crime, and Disorder in New York City. JAMA Netw Open. 2023;6(11):e2342228. doi:10.1001/jamanetworkopen.2023.42228 Key Points Question What trends in crime and disorder were associated with the opening of 2 overdose...
Overdose Prevention Centers, Crime, and Disorder in New York City.pdf
  • Подробнее о Overdose Prevention Centers, Crime, and Disorder in New York City
  • Добавить комментарий
Jose Luis Vazquez Martinez

Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis

Jose Luis Vazquez Martinez - 8 November 2023
Source: Walley, A. Y., Xuan, Z., Hackman, H. H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad, A., ... & Ozonoff, A. (2013). Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. Bmj, 346. Abstract Objective...
Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts interrupted time series analysis.pdf
  • Подробнее о Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis
  • Добавить комментарий
Jose Luis Vazquez Martinez

presentaciones/slides webinar Nov 7, 2023

Jose Luis Vazquez Martinez - 7 November 2023
Beatríz Mesías 7 nov 2023.pdf
Carlos Damín 7 nov 2023.pdf
Luz Adriana Rivera reduccion de riesgos y daños Risaralda 7 nov 2023.pdf
  • Подробнее о presentaciones/slides webinar Nov 7, 2023
  • Добавить комментарий
Jose Luis Vazquez Martinez

Guía para el uso de metadona en usuarios adultos con VIH dependientes de la heroína intravenosa

Jose Luis Vazquez Martinez - 7 Noviembre 2023
Fuente: https://www.gob.mx/cms/uploads/attachment/file/441106/Gu_a_metadona_reimpresi_n_2018.pdf La guía se puede descargar aquí: 👇
Gu_a_metadona_reimpresi_n_2018 Martha Romero.pdf
  • Подробнее о Guía para el uso de metadona en usuarios adultos con VIH dependientes de la heroína intravenosa
  • Добавить комментарий
Jose Luis Vazquez Martinez

Amapola, lindísima amapola: de los opiáceos y los opioides, utilidad y riesgos

Jose Luis Vazquez Martinez - 21 Septiembre 2023
Fuente: Herrera Solís, A., Ostos Valverde, A., Ruiz Contreras, A. E., Méndez Díaz, M., Cortés Morelos, J., Chavira Estefan, S. D. C., & Prospéro García, O. E. (2023). Amapola, lindísima amapola: de los opiáceos y los opioides, utilidad y riesgos. Revista de la Facultad de Medicina (México), 66(3), 8...
Amapola, lindísima amapola de los opiáceos y los opioides, utilidad y riesgos.pdf
  • Подробнее о Amapola, lindísima amapola: de los opiáceos y los opioides, utilidad y riesgos
  • Добавить комментарий
Jose Luis Vazquez Martinez

Integrating Opioid Use Disorder Treatment Into Primary Care Settings

Jose Luis Vazquez Martinez - 11 August 2023
Source: Austin EJ, Chen J, Briggs ES, et al. Integrating Opioid Use Disorder Treatment Into Primary Care Settings. JAMA Netw Open. 2023;6(8):e2328627. doi:10.1001/jamanetworkopen.2023.28627 Key Points Question What are multidisciplinary primary care team perspectives on barriers and facilitators to...
Integrating Opioid Use Disorder Treatment Into Primary Care Settings_1.pdf
  • Подробнее о Integrating Opioid Use Disorder Treatment Into Primary Care Settings
  • 1 комментарий
  • Добавить комментарий
Jose Luis Vazquez Martinez

Fentanyl Overdoses and Their Public Health Consequences

Jose Luis Vazquez Martinez - 21 June 2023
June 21, 2023 Presenter: Jim Caruso, M.D., Chief Medical Examiner/Coroner, City and County of Denver
Fentanyl and Public Health Jim Caruso Denver.pdf
  • Подробнее о Fentanyl Overdoses and Their Public Health Consequences
  • Добавить комментарий
Jose Luis Vazquez Martinez

Farmacología de los analgésicos opioides

Jose Luis Vazquez Martinez - 21 Junio 2023
Presentación realizada por Lucía Hipólito el 21 de junio del 2023
Lucía Hipolito fentanilo 21 junio 2023.pdf
  • Подробнее о Farmacología de los analgésicos opioides
  • Добавить комментарий
Jose Luis Vazquez Martinez

El Fentanilo en las Américas: un problema actual

Jose Luis Vazquez Martinez - 21 Junio 2023
Presentación realizada por Marya Hynes el 21 de junio del 2023
Marya Hynes fentanilo 21 junio 2023.pdf
  • Подробнее о El Fentanilo en las Américas: un problema actual
  • Добавить комментарий
Jose Luis Vazquez Martinez

Fentanyl in the Americas: A Current Problem

Jose Luis Vazquez Martinez - 21 June 2023
Presentation by Marya Hynes June 21, 2023
Marya Hynes fentanyl June 21 2023.pdf
  • Подробнее о Fentanyl in the Americas: A Current Problem
  • Добавить комментарий

Нумерация страниц

  • Текущая страница 1
  • Страница 2
  • Страница 3
  • Страница 4
  • Следующая страница ››
  • Последняя страница Last »

Upcoming Events

There aren't any upcoming events
All Events
Связаться с нами

Stay Connected

Newsletter

ISSUP is funded by the U.S. Department of State via the Bureau of International Narcotics and Law Enforcement Affairs (INL). INL works to keep Americans safe by countering crime, illegal drugs, and instability abroad.

Copyright © International Society of Substance Use Prevention and Treatment Professionals Privacy Policy